Immunodeviation
| Zeile 11: | Zeile 11: | ||
{{tp|p=32341531|t=ä. Could BCG be used to protect against COVID-19?|pdf=|usr=}} | {{tp|p=32341531|t=ä. Could BCG be used to protect against COVID-19?|pdf=|usr=}} | ||
{{tp|p=32372835|t=2020. Trials of BCG vaccine will test for covid-19 protection |pdf=|usr=}} | {{tp|p=32372835|t=2020. Trials of BCG vaccine will test for covid-19 protection |pdf=|usr=}} | ||
| − | + | {{tp|p=32359402|t=2020. Considering BCG vaccination to reduce the impact of COVID-19 |pdf=|usr=}} | |
{{tp|p=32339299|t=2020. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?|pdf=|usr=}} | {{tp|p=32339299|t=2020. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?|pdf=|usr=}} | ||
{{tp|p=32330314|t=2020. Is BCG vaccination affecting the spread and severity of COVID-19?|pdf=|usr=}} | {{tp|p=32330314|t=2020. Is BCG vaccination affecting the spread and severity of COVID-19?|pdf=|usr=}} | ||
| + | |||
| + | {{tp|p=32408071|t=2020. Relation between BCG coverage rate and COVID-19 infection worldwide |pdf=|usr=}} | ||
| + | {{tp|p=C7136957|t=ä. Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic?|pdf=|usr=}} | ||
| + | |||
| + | |||
'''Devvac Hepatitis A''' | '''Devvac Hepatitis A''' | ||
| Zeile 28: | Zeile 33: | ||
{{tp|p=32358579|t=ä. Will helminth co-infection modulate COVID-19 severity in endemic regions?|pdf=|usr=}} | {{tp|p=32358579|t=ä. Will helminth co-infection modulate COVID-19 severity in endemic regions?|pdf=|usr=}} | ||
| − | + | '''Devacc''' | |
| + | {{ttp|p=32240961|t=2020. Routine childhood immunization may protect against COVID-19 |pdf=|usr=}} | ||
| + | {{tp|p=32387756|t=2020. SARS ? CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis) |pdf=|usr=}} | ||
Version vom 18. Juni 2020, 13:56 Uhr
Macrophages
32335290 2020. A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection
32374474 2020. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells
Devvac BCG
32379923 2020. Is BCG vaccination causally related to reduced COVID-19 mortality?
32327396 ä. COVID-19 and Bacillus Calmette-Guerin: What is the Link?
32358227 2020. Demystifying BCG Vaccine and COVID-19 Relationship
32341531 ä. Could BCG be used to protect against COVID-19?
32372835 2020. Trials of BCG vaccine will test for covid-19 protection
32359402 2020. Considering BCG vaccination to reduce the impact of COVID-19
32339299 2020. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
32330314 2020. Is BCG vaccination affecting the spread and severity of COVID-19?
32408071 2020. Relation between BCG coverage rate and COVID-19 infection worldwide
C7136957 ä. Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic?
Devvac Hepatitis A
32279655 2020. Can Hepatitis A Vaccine Provide Protection Against COVID-19?
Devvac Measles
32238614 2020. Measles Immunization: Worth Considering Containment Strategy for SARS-CoV-2 Global Outbreak
Devvac Influenza
32361099 2020. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19
Helminthiosis
32358579 ä. Will helminth co-infection modulate COVID-19 severity in endemic regions?
Devacc
| 32240961 2020. Routine childhood immunization may protect against COVID-19 |
32387756 2020. SARS ? CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis)
anybody remembers old lit on mcns: acacia akazien-extrakt
nothing
Balneotherapy
32300868 ä. Balneotherapy and human immune function in the era of COVID-19
